ダイト(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4577/E24187 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2023/09/01 | 日証協 | 60,770株 | -18.91% | 121,597株 | +127.01% | 79,170株 | -22.21% | 107,471株 | +1597.54% |
2023/08/25 | 日証協 | 74,940株 | +8.35% | 53,564株 | +157.25% | 101,775株 | +3.31% | 6,331株 | -25.53% |
2023/08/18 | 日証協 | 69,164株 | -18.47% | 20,822株 | +404.29% | 98,517株 | -17.29% | 8,501株 | -16.66% |
2023/08/10 | 日証協 | 84,831株 | -10.89% | 4,129株 | -83.98% | 119,105株 | -6.71% | 10,200株 | -71.21% |
2023/08/04 | 日証協 | 95,202株 | -4.06% | 25,773株 | +331.13% | 127,676株 | -35.12% | 35,433株 | +36.66% |
2023/07/28 | 日証協 | 99,226株 | +6.23% | 5,978株 | -91.57% | 196,796株 | +2.9% | 25,928株 | -63.83% |
2023/07/21 | 日証協 | 93,408株 | -22.44% | 70,938株 | +3.33% | 191,250株 | -13.53% | 71,677株 | -7.15% |
2023/07/14 | 日証協 | 120,440株 | +20.07% | 68,649株 | +80.32% | 221,174株 | +10.49% | 77,200株 | +61.97% |
2023/07/07 | 日証協 | 100,310株 | +3.8% | 38,070株 | +309.22% | 200,167株 | -8.04% | 47,663株 | +34.1% |
2023/06/30 | 日証協 | 96,634株 | -8.7% | 9,303株 | -82.61% | 217,660株 | +3.29% | 35,544株 | +46.39% |
2023/06/23 | 日証協 | 105,838株 | +7.46% | 53,500株 | +507.26% | 210,721株 | +3.36% | 24,280株 | +68.02% |
2023/06/16 | 日証協 | 98,494株 | -11.99% | 8,810株 | -90.39% | 203,877株 | -9.07% | 14,451株 | -18.24% |
2023/06/09 | 日証協 | 111,909株 | +66.64% | 91,649株 | -21.95% | 224,208株 | -14.18% | 17,675株 | -93.56% |
2023/06/02 | 日証協 | 67,157株 | +23.6% | 117,417株 | +1626.72% | 261,241株 | +2.75% | 274,607株 | +100.32% |
2023/05/26 | 日証協 | 54,333株 | -28.25% | 6,800株 | -82.01% | 254,253株 | +113.22% | 137,087株 | +59.63% |
2023/05/19 | 日証協 | 75,722株 | +0.22% | 37,800株 | +57.94% | 119,244株 | +4.44% | 85,880株 | +59.92% |
2023/05/12 | 日証協 | 75,554株 | -41.07% | 23,933株 | +9999.99% | 114,175株 | -19.41% | 53,701株 | -4.18% |
2023/05/02 | 日証協 | 128,210株 | -1.08% | 87株 | -99.79% | 141,675株 | +0.07% | 56,043株 | +3429.16% |
2023/04/28 | 日証協 | 129,610株 | +4.32% | 41,331株 | +127.61% | 141,574株 | -8.83% | 1,588株 | -54.3% |
※株式分割は考慮していませんのでご注意ください。
Page Top